- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jubilant Ingrevia Ltd (JUBN)
Jubilant Ingrevia Ltd stock price live, this page displays NSE JUBN stock exchange data. View the JUBN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jubilant Ingrevia Ltd real time stock price chart below.
What Is the Jubilant Ingrevia Ltd Stock Price Today?
The Jubilant Ingrevia Ltd stock price today is 700.80.
What Is the Stock Symbol for Jubilant Ingrevia Ltd?
The stock symbol for Jubilant Ingrevia Ltd is ""JUBN.""
What Stock Exchange Does Jubilant Ingrevia Ltd Trade On?
Jubilant Ingrevia Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Ingrevia Ltd a Good Stock to Buy?
Determining whether Jubilant Ingrevia Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUBN quote. (ISIN: INE0BY001018)
What Is the Jubilant Ingrevia Ltd Stock Price Today?
The Jubilant Ingrevia Ltd stock price today is 700.80.
What Is the Stock Symbol for Jubilant Ingrevia Ltd?
The stock symbol for Jubilant Ingrevia Ltd is ""JUBN.""
What Stock Exchange Does Jubilant Ingrevia Ltd Trade On?
Jubilant Ingrevia Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Ingrevia Ltd a Good Stock to Buy?
Determining whether Jubilant Ingrevia Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUBN quote. (ISIN: INE0BY001018)
700.80
-7.50(-1.06%)
Closed·
Fair Value
An estimate of a Jubilant Ingrevia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
695.00
711.90
52 wk Range
535.20
885.00
JUBN Scorecard
Full Analysis
Impressive gross profit margins
JUBN is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Jubilant Ingrevia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
695.00711.90
52 wk Range
535.20885.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.71%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.71%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JUBN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Jubilant Ingrevia's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
967.67
Upside
+38.08%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Jubilant Ingrevia Ltd Company Profile
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. In addition, it provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. The company serves pharmaceutical, nutrition, agrochemical, consumer, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
Compare JUBN to Peers and Sector
Metrics to compare | JUBN | Peers Peers - average of corresponding metrics from companies closely matching JUBN: ANURAS, AARTIIND, LXCHEM, NAVINFLUOR, CHEMCON | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipJUBNPeersSector |
|---|---|---|---|---|
P/E Ratio | 39.9x | 32.8x | 2.2x | |
PEG Ratio | 0.67 | 0.16 | 0.00 | |
Price/Book | 3.8x | 3.0x | 1.6x | |
Price / LTM Sales | 2.6x | 1.9x | 1.3x | |
Upside (Analyst Target) | 29.9% | 4.5% | 20.0% | |
Fair Value Upside | Unlock | −4.6% | 2.4% | Unlock |
Analyst Ratings
2 Buy
1 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 967.67
(+38.08% Upside)
Earnings
Latest Release
Jul 31, 2025
EPS / Forecast
4.80 / --
Revenue / Forecast
10.38B / --
People Also Watch
FAQ
What Stock Exchange Does Jubilant Ingrevia Trade On?
Jubilant Ingrevia is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Jubilant Ingrevia?
The stock symbol for Jubilant Ingrevia is "JUBN."
What Is the Jubilant Ingrevia Market Cap?
As of today, Jubilant Ingrevia market cap is 110.81B.
What Is Jubilant Ingrevia's Earnings Per Share (TTM)?
The Jubilant Ingrevia EPS (TTM) is 17.56.
When Is the Next Jubilant Ingrevia Earnings Date?
Jubilant Ingrevia will release its next earnings report on 14 Oct 2025.
From a Technical Analysis Perspective, Is JUBN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Jubilant Ingrevia Stock Split?
Jubilant Ingrevia has split 0 times.
How Many Employees Does Jubilant Ingrevia Have?
Jubilant Ingrevia has 2139 employees.
What is the current trading status of Jubilant Ingrevia (JUBN)?
As of 09 Aug 2025, Jubilant Ingrevia (JUBN) is trading at a price of 700.80, with a previous close of 708.30. The stock has fluctuated within a day range of 695.00 to 711.90, while its 52-week range spans from 535.20 to 885.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.